Back Link
Reader View

Zymeworks EVP, head of R&D Adam Schayowitz sells $357,557 in stock.

www.investing.com · October 9, 2026 · 23:01
Paywall detected

This article has a paywall

The publisher blocks direct access to this article.

Open link